Table 1. Reagent-related adverse events.
Grade | 0.1 mg/kg (N = 23) | 0.5 mg/kg (N = 3) | 1.0 mg/kg (N = 23) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
1–2 | 3 | 4 | 1–2 | 3 | 4 | 1–2 | 3 | 4 | ||
Total events | 67 | 8 | 1 | 14 | 2 | 60 | 9 | 2 | ||
Non-hematological | ||||||||||
Skin and subcutaneous tissue | ||||||||||
Rash | 15 | 1 | 2 | 12 | ||||||
Pruritus | 1 | |||||||||
Drug eruption | 1 | |||||||||
Erythema | 2 | |||||||||
Papules | 1 | |||||||||
Cutaneous papilloma | 1 | |||||||||
Hematological | ||||||||||
Lymphopenia | 12 | 4 | 1 | 2 | 7 | 5 | 2 | |||
Hypophosphatemia | 1 | 1 | ||||||||
GGT increased | 1 | 2 | ||||||||
ALT increased | 3 | 1 | ||||||||
AST increased | 2 | 1 | 1 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, Gamma-glutamyltransferase